We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » SEC Rejects BIO Request to Exempt Some Firms From SOX
SEC Rejects BIO Request to Exempt Some Firms From SOX
May 30, 2006
Biotech firms are in a race against the clock to get broad Sarbanes-Oxley (SOX) reforms before the next round of filings are due now that the SEC has denied industry’s request to exclude smaller companies from SOX reporting and auditing requirements, an industry source says.